RD Therapeutics and Rapid Dose Therapeutics Participate in the CEPI Global Pandemic Preparedness Summit and Support the #100DaysMission

RD Therapeutics and Rapid Dose Therapeutics Participate in the CEPI Global Pandemic Preparedness Summit and Support the #100DaysMission
CANNANNEW REPORT

Value of needle-free vaccination, such as the QuickStrip™, will be discussed BURLINGTON, Ontario–(BUSINESS WIRE)–#100DaysMission–Rapid Dose Therapeutics Corp. (“RDT” or the“Company”) (CSE: DOSE), a Canadian biotechnology company focused on health and wellness leveraging an innovative, proprietary oral delivery medication and nutraceutical platform, along with their UK and European partner RD Therapeutics, proudly supports the #100DaysMission. As an invited guest, Ailene Thiel, CEO, RD Therapeutics is participating in the March 7 & 8 Coalition for Epidemic Preparedness Innovations’ (CEPI) Global Pandemic Preparedness Summit. The Summit is bringing together world leaders from governments, international agencies, science and academia, industry, philanthropy, and civil society to continue the valuable work being done to meet global unmet medical needs and mobilize critical resources needed for CEPI’s $3.5 billion pandemic plan to ensure a more equitable response for future pandemics. Specifically, the Summit will explore how to respond to the next “Disease X” by making safe, effective vaccines (including needle-free solutions), therapeutics, and diagnostics within 100 days of the World Health Organization’s (WHO) identification of a new pathogen, and identifying how the world can boost its ability to scale up production of vaccines in the future. The #100DaysMission has recognized the need to compress vaccine development timelines in an effort to save lives and trillions of dollars of economic damage. Together, RD Therapeutics and Rapid Dose Therapeutics are committed to enabling equitable access to vaccines through the development of a temperature and humidity-stable, oral (i.e. needle-free) delivery platform (QuickStrip™) for vaccines.The QuickStrip vaccine platform is expected to decrease time to market and increases geographic reach by eliminating costly and logistically complicated cold-chain transportation and storage requirements while reducing healthcare costs associated with vaccination programs by removing the need for medical professional administration. Ailene Thiel, CEO, RD Therapeutics, said: “We are committed to enabling equitable access to vaccines.…

Excerpt only …
READ MORE BELOW
Source : RD Therapeutics and Rapid Dose Therapeutics Participate in the CEPI Global Pandemic Preparedness Summit and Support the #100DaysMission

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.